S&P 500 Down Over 1%; Bit Brother Shares Plummet
U.S. stocks traded lower toward the end of trading, with the S&P 500 dropping more than 1% on Wednesday.
Bit Brother Plunges After $7.1M Equity Offering
Bit Brother Ltd (NASDAQ:BTB) said it has entered into a securities purchase agreement with certain accredited investors to sell $7.1 million…
Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ program members.
US Stocks Turn Lower; Dow Dips Over 300 Points
U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 300 points on Wednesday.
Why DBV Technologies Shares Are Trading Higher By 38%; Here Are 26 Stocks Moving Premarket
Gainers
Expion360 Inc. (NASDAQ: XPON) shares rose 152% to $2.47 in pre-market trading. Expion360 been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trailer available through SUV dealerships nationwide.
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday’s Mid-Day Session
Gainers
Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 49 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Bit Brother Adopts 1 For 15 Reverse Share Split
Bit Brother Ltd (NASDAQ: BTB) said that a 1 for 15 reverse split of its class A ordinary shares was approved by the company's board of directors on September 29, 2022.
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.